Dose and volume de-escalation for HPV-associated oropharyngeal cancer: Long-term follow-up of the OPTIMA trial.

被引：0
|
作者：
Rosenberg, Ari
Agrawal, Nishant
Pearson, Alexander T.
Seiwert, Tanguy Y.
Gooi, Zhen
Blair, Elizabeth A.
Cursio, John
Howard, Adam
Chin, Jeffrey
Foster, Corey Christian
Kochanny, Sara
Lingen, Mark W.
Haraf, Daniel J.
Vokes, Everett E.
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Univ Chicago Med, Chicago, IL USA
[4] Univ Chicago, Med Ctr, Chicago, IL 60637 USA
[5] Univ Chicago Med, Dept Radiat & Cellular Oncol, Chicago, IL USA
[6] Univ Chicago, Med & Biol Sci, Chicago, IL USA
[7] Univ Chicago Med, Dept Med, Sect Hematol Oncol, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6575
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Screening for Extranodal Extension with Deep Learning: Evaluation in ECOG-ACRIN E3311, a Randomized De-Escalation Trial for HPV-Associated Oropharyngeal Carcinoma
    Kann, B. H.
    Likitlersuang, J.
    Ye, Z.
    Aneja, S.
    Bakst, R. L.
    Kelly, H. R.
    Juliano, A.
    Payabvash, S.
    Guenette, J. P.
    Uppaluri, R.
    Margalit, D. N.
    Schoenfeld, J. D.
    Tishler, R. B.
    Haddad, R. I.
    Aerts, H.
    Garcia, J. J.
    Flamand, Y.
    Subramaniam, R. M.
    Burtness, B.
    Ferris, R. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S26 - S27
  • [32] Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience
    Rosenberg, Ari J.
    Agrawal, Nishant
    Pearson, Alexander
    Gooi, Zhen
    Blair, Elizabeth
    Cursio, John
    Juloori, Aditya
    Ginat, Daniel
    Howard, Adam
    Chin, Jeffrey
    Kochanny, Sara
    Foster, Corey
    Cipriani, Nicole
    Lingen, Mark
    Izumchenko, Evgeny
    Seiwert, Tanguy Y.
    Haraf, Daniel
    Vokes, Everett E.
    ORAL ONCOLOGY, 2021, 122
  • [33] Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in With Gout
    Coleman, George B.
    Dalbeth, Nicola
    Frampton, Chris
    Haslett, Janine
    Drake, Jill
    Su, Isabel
    Horne, Anne M.
    Stamp, Lisa K.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (12) : 1372 - 1378
  • [34] Tumor Volume Predicts for Baseline Hypoxia Status in HPV Related Oropharyngeal Carcinomas (OPC) that Underwent Major Radiation De-escalation: The 30 Reduction in Oropharyngeal Cancer Trial
    Han, J.
    Diplas, B.
    Paudyal, R.
    Oh, J. H.
    Sherman, E.
    Schoder, H.
    Hatzoglou, V.
    Yu, Y.
    Wong, R. J.
    Wray, R.
    Boyle, J. O.
    Grkovski, M.
    Humm, J.
    Dave, A.
    Riaz, N.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E317 - E317
  • [35] Are we ready for biomarker driven, radiation dose-adaptable de-escalation studies for HPV plus oropharyngeal cancer?
    Misiukiewicz, Krzysztof
    Worona, Leslie
    Ramos, Emily J.
    Bakst, Richard Lorne
    Sindhu, Kunal K.
    Westra, Wiliam J.
    Roof, Scott
    Posner, Marshall R.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Long-Term Follow-up of a Prospective Study of Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer
    Welsh, J. W.
    Chen, D.
    Menon, H.
    Seyedin, S. N.
    Hofstetter, W.
    Ajani, J.
    Chang, J. Y.
    Gomez, D. R.
    Amini, A.
    Swisher, S. G.
    Blum, M.
    Younes, A.
    Nguyen, Q. N.
    Erasmus, J.
    Bhutani, M. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E182 - E182
  • [37] A Randomized Trial of Radiotherapy vs. Trans-Oral Surgery for Treatment De-Escalation in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (ORATOR2)
    Palma, D. A.
    Prisman, E.
    Berthelet, E.
    Tran, E.
    Hamilton, S. N.
    Wu, J.
    Eskander, A.
    Higgins, K.
    Karam, I.
    Poon, I.
    Husain, Z. A.
    Enepekides, D.
    Hier, M.
    Sultanem, K.
    Richardson, K.
    Mlynarek, A.
    Johnson-Obaseki, S.
    Eapen, L.
    Odell, M.
    Bayley, A. J.
    Dowthwaite, S.
    Jackson, J. E.
    Dzienis, M.
    O'Neil, J.
    Chandarana, S.
    Banerjee, R. N.
    Hart, R.
    Chung, J.
    Tenenholz, T. C.
    Krishnan, S.
    Le, H. V.
    Yoo, J.
    Mendez, A.
    Winquist, E.
    Kuruvilla, S.
    Stewart, P.
    Warner, A.
    Mitchell, S.
    Chen, J.
    Parker, C.
    Wehrli, B.
    Kwan, K.
    Theurer, J.
    Sathya, J.
    Hammond, J. A.
    Read, N. E.
    Venkatesan, V. M.
    MacNeil, D.
    Fung, K.
    Nichols, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (05): : 1324 - 1325
  • [38] Long-term follow-up of cancer survivors
    DeLaat, CA
    Meadows, AT
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (06) : 463 - 465
  • [39] Phase-II-Studie zur Therapiedeeskalation bei HPV-assoziierten Oropharynxkarzinomen. Kommentar IIPhase II study on treatment de-escalation in HPV-associated oropharyngeal cancer
    Robert Michael Hermann
    Hans Christiansen
    Strahlentherapie und Onkologie, 2022, 198 (8) : 755 - 758
  • [40] OPTIMAd-A Phase 2 Trial of Induction Chemotherapy Response-Stratified Radiation Therapy Dose and Volume De-escalation for HPV plus Oropharyngeal Cancer: Efficacy, Toxicity, and HPV Subtype Analysis
    Seiwert, T.
    Melotek, J. M.
    Foster, C. C.
    Blair, E. A.
    Karrison, T. G.
    Agrawal, N.
    Portugal, L.
    Gooi, Z.
    Stenson, K. M.
    Brisson, R. J.
    Arshad, S.
    Dekker, A.
    Kochanny, S.
    Saloura, V.
    Spiotto, M. T.
    Villaflor, V. M.
    Haraf, D. J.
    Vokes, E. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1309 - 1309
12345